ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
Published in: | Annals of Oncology |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Other Authors: | |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Elsevier BV
2020
|
Subjects: | |
Online Access: | http://dx.doi.org/10.1016/j.annonc.2020.02.006 https://api.elsevier.com/content/article/PII:S0923753420360415?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753420360415?httpAccept=text/plain |
Description not available. |